Literature DB >> 28703132

Association of a functional TNF variant with Plasmodium falciparum parasitaemia in a congolese population.

T N Nguyen1,2,3, S Baaklini1,2, F Koukouikila-Koussounda4,5, M Ndounga6, M Torres1,2, L Pradel1,2, F Ntoumi4,5,7, P Rihet1,2.   

Abstract

Several studies have provided evidence of both helpful and harmful effects of TNF on the outcome of Plasmodium falciparum malaria infection. Several TNF polymorphisms that are located within non-coding regions have been associated with parasitaemia, mild malaria or severe malaria. We investigated the association of TNF1304 (rs3093664), TNF-308 (rs1800629), TNF-238 (rs361525) and TNF-244 (rs673) with mild malaria and symptomatic maximum parasitaemia in a population-based design (n=310). We obtained nominal evidence for an association between symptomatic maximum parasitaemia and TNF-308, TNF-238, and TNF-244 on the one hand, and between the number of mild malaria attacks and TNF-244 on the other hand. After accounting for multiple tests, we confirmed the association of symptomatic maximum parasitaemia with TNF-244. We further provide bioinformatics and experimental evidence that TNF-244 has a cis-regulatory effect. This is the first report that emphasizes the potential role of TNF-244 in malaria.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28703132     DOI: 10.1038/gene.2017.13

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  36 in total

1.  TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans.

Authors:  J Wattavidanage; R Carter; K L Perera; A Munasingha; S Bandara; D McGuinness; A R Wickramasinghe; H K Alles; K N Mendis; S Premawansa
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

Review 3.  Experimental models of cerebral malaria.

Authors:  C Engwerda; E Belnoue; A C Grüner; L Rénia
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

4.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

5.  Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis.

Authors:  F Y Liew; C Parkinson; S Millott; A Severn; M Carrier
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

6.  A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system.

Authors:  Mahdad Karimi; Lauren C Goldie; Mark N Cruickshank; Eric K Moses; Lawrence J Abraham
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

7.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso.

Authors:  Laurence Flori; Serge Sawadogo; Christelle Esnault; Nicolas Frédéric Delahaye; Francis Fumoux; Pascal Rihet
Journal:  Hum Mol Genet       Date:  2003-02-15       Impact factor: 6.150

9.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

10.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Cell death pathologies: targeting death pathways and the immune system for cancer therapy.

Authors:  Francesca Pentimalli; Sandro Grelli; Nicola Di Daniele; Gerry Melino; Ivano Amelio
Journal:  Genes Immun       Date:  2018-12-19       Impact factor: 2.676

2.  Association between TNF-ɑ-308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis.

Authors:  Fengming Yang; Ke Wei; Zhiqiang Qin; Chuchu Shao; Yongqian Shu; Hua Shen
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

Review 3.  Genetics of Malaria Inflammatory Responses: A Pathogenesis Perspective.

Authors:  Carlos Penha-Gonçalves
Journal:  Front Immunol       Date:  2019-07-30       Impact factor: 7.561

Review 4.  Recent Advances in Understanding the Inflammatory Response in Malaria: A Review of the Dual Role of Cytokines.

Authors:  Gabriela Loredana Popa; Mircea Ioan Popa
Journal:  J Immunol Res       Date:  2021-11-08       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.